Viewing nowCombinationAlendroplus D Tablets
Sodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Granules 53.33mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 201203534 · Approved 2012.04.27 · Insurance code 641805200
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in both postmenopausal women and men.
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Discontinuation should be considered after 3~5 years of treatment in patients at low risk of fracture. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages, foods, and medicines, including mineral water and barley tea, may reduce the absorption of alendronate (see “Drug Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce the absorption of alendronate in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it, and remain upright until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients who do not get enough calcium and vitamin D from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides the equivalent of one week’s supply of daily vitamin D at 400 IU or 800 IU. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Use in elderly patients (65 years and older): No dose adjustment is necessary. Use in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.
Children and adolescents (under 18 years): The safety and efficacy in children and adolescents have not been established.
This medication may irritate the upper gastrointestinal mucosa, potentially causing esophagitis, esophageal ulcers, or esophageal erosion. If you experience symptoms such as difficulty swallowing, pain behind the sternum, or heartburn during treatment, you should stop taking the medication immediately and consult a doctor. Always take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. Use with caution in individuals with gastrointestinal diseases such as esophageal disorders, gastritis, duodenitis, or ulcers. Do not take this medication if you have esophageal motility disorders, are unable to sit or stand upright for 30 minutes or more, are allergic to any component of this medication, have hypocalcemia, or have certain genetic disorders. Gastrointestinal symptoms such as abdominal pain, dyspepsia, nausea, diarrhea, and constipation may occur, as well as musculoskeletal pain, headaches, and dizziness. This medication may interfere with the absorption of calcium supplements and antacids, so you should space them apart by at least 30 minutes. Caution should be exercised when using it in conjunction with aspirin or non-steroidal anti-inflammatory drugs due to an increase in gastrointestinal side effects. During pregnancy, it should only be used when necessary, considering the risks to the fetus and the mother, and lactating women should consult a doctor before taking it. Not recommended for children, and caution is needed for elderly patients or those with severely impaired kidney function. Always take this medication immediately upon waking in the morning on an empty stomach with plenty of water, and do not eat or lie down for 30 minutes after taking it. Do not chew or suck on this medication, and strictly adhere to the administration method to reduce the risk of esophageal irritation. In case of overdose, do not induce vomiting and immediately contact a medical institution as hypocalcemia or gastrointestinal side effects may occur. Store in a place where children cannot reach and do not transfer to other containers.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, osteomyelitis, jawbone necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, episcleritis, scleritis, external auditory canal cholesteatoma, urticaria, angioedema, myalgia, lethargy, weakness, fever, hypocalcemia, peripheral edema, nasopharyngitis, gastroesophageal reflux disease
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. The temperature should be kept between 1 to 30 degrees Celsius at room temperature. It is also advisable to store it in a dark place, avoiding direct sunlight.
White to grayish-white rectangular tablets
4 tablets (4 tablets/PTPX1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Trihydrate 91.37mg · Cholecalciferol Concentrate Granules 53.33mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Granules 26.67mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Granules 53.33mg
Tablet · Prescription medication · Combination
Han-guk Organon Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.